AlphaStar Capital Management’s Gilead Sciences GILD Stock Holding History

AlphaStar Capital Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-5,800	Closed	-$486K	–	264
2024 Q3	$486K	Buy	+5,800	New	+$443K	0.04%	235
2024 Q2	–	Sell	-3,226	Closed	-$236K	–	315
2024 Q1	$236K	Buy	+3,226	New	+$248K	0.02%	266
2023 Q1	–	Sell	-2,738	Closed	-$235K	–	308
2022 Q4	$235K	Buy	+2,738	New	+$217K	0.02%	276
2022 Q1	–	Sell	-11,510	Closed	-$826K	–	395
2021 Q4	$826K	Buy	11,510 +61	+0.5%	+$4.2K	0.07%	199
2021 Q3	$767K	Buy	11,449 +1,763	+18%	+$124K	0.05%	225
2021 Q2	$667K	Buy	9,686 +1,843	+23%	+$123K	0.09%	166
2021 Q1	$507K	Buy	+7,843	New	+$506K	0.08%	153
2020 Q4	–	Sell	-8,172	Closed	-$495K	–	214
2020 Q3	$495K	Buy	8,172 +3,028	+59%	+$210K	0.1%	124
2020 Q2	$394K	Buy	+5,144	New	+$394K	0.08%	132

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AlphaStar Capital Management's GILD Position: Q4 2024 in Review

AlphaStar Capital Management sold out of Gilead Sciences (GILD) in Q4 2024, closing a stake of 5,800 shares — an estimated $486K sold.

AlphaStar Capital Management first reported a position in GILD in Q2 2020 and held it in 9 quarters. The position peaked at $826K in Q4 2021. 1,887 funds tracked by Wall St. Rank hold GILD as of Q4 2024.

AlphaStar Capital Management reported no remaining Gilead Sciences position as of Q4 2024 after selling out during the quarter.
AlphaStar Capital Management sold 5,800 Gilead Sciences shares in Q4 2024, an estimated $486K.
AlphaStar Capital Management first reported a position in Gilead Sciences in Q2 2020 and held it in 9 quarters.
AlphaStar Capital Management's Gilead Sciences position peaked at $826K in Q4 2021.
1,887 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2024.

Based on AlphaStar Capital Management's 13F filing for Q4 2024, filed 28 Jan 2025.